Drug Trial Radar · NCT01714544
Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Jul 23, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Oct 2012
Primary completion
Mar 2013
Sponsor
- Lead sponsor
- Promius Pharma, LLCIndustry
- Sponsor type
- Industry
- First posted
- Oct 26, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days.
Conditions
- Psoriasis
Interventions
Cloderm CreamDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Investigator's Global Assessment (IGA)Time frame: 28 days
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Radiant Research, Inc.
Cincinnati, Ohio
Oregon Medical Research
Portland, Oregon
DermResearch, Inc.
Austin, Texas
Research Across America
Dallas, Texas
Madison Skin and Research, Inc.
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.